News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sigma Global Corporation Launches Biometis Joint Venture



10/19/2005 5:13:18 PM

PLANO, Texas--(BUSINESS WIRE)--Oct. 5, 2005--Sigma Global Corporation (Pink Sheets:SGGC), a leading direct-to-consumer provider of medical devices and pharmaceuticals today announced that it has launched Biometis, a medical device and pharmaceutical joint venture with Stason Pharmaceuticals, Inc. Biometis is a Texas corporation with operations in both California and Texas. Biometis intends to introduce its own line of medical devices and generic pharmaceuticals aimed at patients with chronic diseases to retailers, institutions and consumer-direct outlets nationwide. Biometis is limited to new medical devices and generic pharmaceuticals jointly developed by the venture.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES